Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Spinal Cord Ependymoma Associated with Neurofibromatosis 1 : Case Report and Review of the Literature

  • Cheng, Hongwei (Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University) ;
  • Shan, Ming (Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University) ;
  • Feng, Chunguo (Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University) ;
  • Wang, Xiaojie (Department of Pathology, The First Affiliated Hospital of Anhui Medical University)
  • Received : 2013.02.01
  • Accepted : 2013.12.16
  • Published : 2014.01.28
Download PDF
⟨ Previous Next ⟩

Abstract

Patients with neurofibromatosis 1 (NF1) are predisposed to develop central nervous system tumors, due to the loss of neurofibromin, an inactivator of proto-oncogene Ras. However, to our knowledge, only three cases of ependymomas with NF1 have been reported in the literature. The authors present a case of NF1 patient with a spinal cord ependymoma. She was referred for about half a year history of increasing numbness that progressed from her fingers to her entire body above the bellybutton. Magnetic resonance imaging revealed a relative-demarcated, heterogeneously enhanced mass lesion accompanied by perifocal edema in C5-7 level, a left-sided T11 spinous process heterogeneously enhanced mass in soft tissue, intervertebral disk hernia in L2-5 level, and widespread punctum enhancing lesion in her scalp and in T11-L5 level. The patient underwent C5-7 laminectomies and total excision of the tumor under operative microscope, and intraoperative ultrasonography and physiological monitoring were used during the surgery. Histopathologically, her tumor was found to be a ependymoma without malignant features (grade II in the World Health Organization classification). Therefore, no adjuvant therapy was applied. Following the operation, the patient showed an uneventful clinical recovery with no evidence of tumor recurrence after one year of follow-up.

Keywords

References

  1. Abbott R : The use of physiological mapping and monitoring during surgery for ependymomas. Childs Nerv Syst 25 : 1241-1247, 2009 https://doi.org/10.1007/s00381-009-0875-x
  2. Aguilera DG, Mazewski C, Schniederjan MJ, Leong T, Boydston W, Macdonald TJ : Neurofibromatosis-2 and spinal cord ependymomas : report of two cases and review of the literature. Childs Nerv Syst 27 : 757-764, 2011 https://doi.org/10.1007/s00381-010-1351-3
  3. Alkhani A, Blooshi M, Hassounah M : Outcome of surgery for intramedullary spinal ependymoma. Ann Saudi Med 28 : 109-113, 2008 https://doi.org/10.4103/0256-4947.51737
  4. Brems H, Beert E, de Ravel T, Legius E : Mechanisms in the pathogenesis of malignant tumours in neurofibromatosis type 1. Lancet Oncol 10 : 508-515, 2009 https://doi.org/10.1016/S1470-2045(09)70033-6
  5. Cnossen MH, van der Est MN, Breuning MH, van Asperen CJ, Breslau-Siderius EJ, van der Ploeg AT, et al. : Deletions spanning the neurofibromatosis type 1 gene : implications for genotype-phenotype correlations in neurofibromatosis type 1? Hum Mutat 9 : 458-464, 1997 https://doi.org/10.1002/(SICI)1098-1004(1997)9:5<458::AID-HUMU13>3.0.CO;2-1
  6. Dilworth JT, Kraniak JM, Wojtkowiak JW, Gibbs RA, Borch RF, Tainsky MA, et al. : Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1. Biochem Pharmacol 72 : 1485-1492, 2006 https://doi.org/10.1016/j.bcp.2006.04.010
  7. Eroes CA, Zausinger S, Kreth FW, Goldbrunner R, Tonn JC : Intramedullary low grade astrocytoma and ependymoma. Surgical results and predicting factors for clinical outcome. Acta Neurochir (Wien) 152 : 611-618, 2010 https://doi.org/10.1007/s00701-009-0577-x
  8. Ferner RE, Huson SM, Thomas N, Moss C, Willshaw H, Evans DG, et al. : Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet 44 : 81-88, 2007 https://doi.org/10.1136/jmg.2007.049122
  9. Graf N : Glioblastoma in children with NF1 : the need for basic research. Pediatr Blood Cancer 54 : 870-871, 2010 https://doi.org/10.1002/pbc.22487
  10. Guillamo JS, Créange A, Kalifa C, Grill J, Rodriguez D, Doz F, et al. : Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1) : a retrospective study of 104 patients. Brain 126 (Pt 1) : 152-160, 2003 https://doi.org/10.1093/brain/awg016
  11. Guyotat J, Metellus P, Giorgi R, Barrie M, Jouvet A, Fevre-Montange M, et al. : Infratentorial ependymomas : prognostic factors and outcome analysis in a multi-center retrospective series of 106 adult patients. Acta Neurochir (Wien) 151 : 947-960, 2009 https://doi.org/10.1007/s00701-009-0417-z
  12. Jett K, Friedman JM : Clinical and genetic aspects of neurofibromatosis 1. Genet Med 12 : 1-11, 2010
  13. Kluwe L, Tatagiba M, Fünsterer C, Mautner VF : NF1 mutations and clinical spectrum in patients with spinal neurofibromas. J Med Genet 40 : 368-371, 2003 https://doi.org/10.1136/jmg.40.5.368
  14. Lakkis MM, Tennekoon GI : Neurofibromatosis type 1. I. General overview. J Neurosci Res 62 : 755-763, 2000 https://doi.org/10.1002/1097-4547(20001215)62:6<755::AID-JNR1>3.0.CO;2-W
  15. Lim BS, Park SQ, Chang UK, Kim MS : Spinal cord tanycytic ependymoma associated with neurofibromatosis type 2. J Clin Neurosci 17 : 922-924, 2010 https://doi.org/10.1016/j.jocn.2009.09.045
  16. Rasmussen SA, Friedman JM : NF1 gene and neurofibromatosis 1. Am J Epidemiol 151 : 33-40, 2000 https://doi.org/10.1093/oxfordjournals.aje.a010118
  17. Rasmussen SA, Yang Q, Friedman JM : Mortality in neurofibromatosis 1 : an analysis using U.S. death certificates. Am J Hum Genet 68 : 1110-1118, 2001 https://doi.org/10.1086/320121
  18. Riffaud L, Vinchon M, Ragragui O, Delestret I, Ruchoux MM, Dhellemmes P : Hemispheric cerebral gliomas in children with NF1 : arguments for a long-term follow-up. Childs Nerv Syst 18 : 43-47, 2002 https://doi.org/10.1007/s00381-001-0534-3
  19. Rodriguez FJ, Perry A, Gutmann DH, O'Neill BP, Leonard J, Bryant S, et al. : Gliomas in neurofibromatosis type 1 : a clinicopathologic study of 100 patients. J Neuropathol Exp Neurol 67 : 240-249, 2008 https://doi.org/10.1097/NEN.0b013e318165eb75
  20. Rosenfeld A, Listernick R, Charrow J, Goldman S : Neurofibromatosis type 1 and high-grade tumors of the central nervous system. Childs Nerv Syst 26 : 663-667, 2010 https://doi.org/10.1007/s00381-009-1024-2
  21. Sharma AS, Emery ME, Metcalfe KM, Sabin HIS, Drake WMD : A case of thoracic cord ependymoma in neurofibromatosis type 1. Endocr Abstr 12 : 17, 2006
  22. Shim KW, Kim DS, Choi JU : The history of ependymoma management. Childs Nerv Syst 25 : 1167-1183, 2009 https://doi.org/10.1007/s00381-009-0900-0
  23. Son DW, Song GS, Han IH, Choi BK : Primary extramedullary ependymoma of the cervical spine : case report and review of the literature. J Korean Neurosurg Soc 50 : 57-59, 2011 https://doi.org/10.3340/jkns.2011.50.1.57
  24. Thakkar SD, Feigen U, Mautner VF : Spinal tumours in neurofibromatosis type 1 : an MRI study of frequency, multiplicity and variety. Neuroradiology 41 : 625-629, 1999 https://doi.org/10.1007/s002340050814
  25. Ueki K, Sasaki T, Ishida T, Kirino T : Spinal tanycytic ependymoma associated with neurofibromatosis type 2--case report. Neurol Med Chir (Tokyo) 41 : 513-516, 2001 https://doi.org/10.2176/nmc.41.513
  26. Zhou H, Miller D, Schulte DM, Benes L, Bozinov O, Sure U, et al. : Intraoperative ultrasound assistance in treatment of intradural spinal tumours. Clin Neurol Neurosurg 113 : 531-537, 2011 https://doi.org/10.1016/j.clineuro.2011.03.006

Cited by

  1. Medullary unidentified bright objects in Neurofibromatosis type 1: a case series vol.18, pp.1, 2014, https://doi.org/10.1186/s12887-018-1067-1